- Home
- ETON vs KRP Comparison
ETON vs KRP Comparison
Compare ETON & KRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ETON | KRP |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ETON | KRP |
|---|---|---|
| Price | $52.31 | $16.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $71.50 | $19.20 |
| AVG Volume (30 Days) | 428.5K | ★ 714.1K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 9.30% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.41 | N/A |
| Revenue | $79,950,000.00 | ★ $333,830,000.00 |
| Revenue This Year | $87.26 | $22.81 |
| Revenue Next Year | $47.21 | $1.91 |
| P/E Ratio | $131.15 | ★ N/A |
| Revenue Growth | ★ 104.94 | 7.93 |
| 52 Week Low | $14.27 | $11.31 |
| 52 Week High | $66.37 | $17.12 |
Technical Indicators
Market Signals| Indicator | ETON | KRP |
|---|---|---|
| Relative Strength Index (RSI) | 47.91 | 72.98 |
| Support Level | $48.58 | $13.99 |
| Resistance Level | $57.00 | N/A |
| Average True Range (ATR) | 2.39 | 0.29 |
| MACD | 0.27 | 0.06 |
| Stochastic Oscillator | 47.46 | 83.13 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
About KRP Kimbell Royalty Partners
Kimbell Royalty Partners LP owns and acquires mineral and royalty interests in oil and natural gas properties throughout the United States. The company's basins and producing regions include areas of interest in the Permian Basin, Mid-Continent, Terryville/Cotton Valley/Haynesville, Appalachian Basin, Eagle Ford, Bakken/Williston Basin, and DJ Basin/Rockies/Niobrara. Its revenues are derived from royalty payments received from operators based on the sale of oil, natural gas and NGL production, as well as the sale of NGLs that are extracted from natural gas during processing.